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The second messenger cGMP is involved in several physi-
ological functions such as smooth muscle relaxation and
inhibition of platelet aggregation. Besides cGMP synthe-
sis, hydrolysis of cGMP by cyclic nucleotide phosphodi-
esterases (PDEs) determines the shape of cGMP signals.
Eleven PDE families are known differing in regulation and
cAMP/cGMP specificity. PDEs are homodimers; each
monomer being composed of different N-terminal regula-
tory domains and a C-terminal catalytic domain highly
conserved between the PDE families. Five PDEs contain a
tandem of so called GAF domains in their N termini that
have been shown to bind cGMP or cAMP. At least in PDEs
2, 5 and 6, binding of cGMP to the GAF domains leads to
stimulation of the enzymes. Here, we focussed on the
GAF-mediated stimulation of PDEs 2 and 5.
PDE2 hydrolyzes both cyclic nucleotides, cGMP and
cAMP; binding of cGMP to the regulatory GAF domains
stimulates cAMP hydrolysis. Because PDE5 lost its regula-
tion by cGMP upon purification, the enzyme has initially
been described as "cGMP-binding cGMP-specific PDE".
Difficulties to analyse a stimulatory effect of cGMP, the
enzyme's substrate, further delayed the recognition of the
cGMP-induced stimulation of PDE5.
Here, we screened cyclic nucleotide analogs to identify lig-
ands specifically binding to the regulatory GAF domains
without binding to the catalytic domains. We used GAF
domain-containing FRET (fluorescence resonance energy
transfer) constructs to study binding of the analogs to the
GAF domains. Several analogs, specific for the GAF
domains of either PDE2 or 5 were identified by this
approach and consecutively analyzed regarding their abil-
ity to stimulate the holoenzymes. PDE 2-mediated cAMP
and cGMP hydrolysis was stimulated 30- and 40-fold by
the analogs, respectively. In PDE5, a 20-fold stimulation
was observed and surprisingly, the stimulation of PDE5
by GAF domain ligands turned out to be rather slow
requiring up to 10 min at low concentrations of the nucle-
otides.
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